Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 29-Apr-13 2:49 PM View:  | Grant Edward A Director | Obagi Medical Products, Inc. (OMPI) | 25-Apr-13 | Disposition | 21,202 | $24.00 | $508,848.00 | (100%) 21.2K to 0 | < 1% |
| 29-Apr-13 2:50 PM View: | Leslie Kristina M Director | Obagi Medical Products, Inc. (OMPI) | 25-Apr-13 | Disposition | 4,890 | $24.00 | $117,360.00 | (100%) 4.89K to 0 | < 1% |
| 29-Apr-13 2:33 PM View: | Hummel Albert F President & CEO Director | Obagi Medical Products, Inc. (OMPI) | 25-Apr-13 | Disposition | 65,787 | $24.00 | $1,578,890.00 | (100%) 65.79K to 0 | < 1% |
| 29-Apr-13 2:39 PM View: | Taylor Mark Thomas Senior Vice President | Obagi Medical Products, Inc. (OMPI) | 25-Apr-13 | Disposition | 12,294 | $24.00 | $295,056.00 | (100%) 12.29K to 0 | < 1% |
| 29-Apr-13 2:41 PM View: | Bartholdson John A. Director | Obagi Medical Products, Inc. (OMPI) | 25-Apr-13 | Disposition | 17,953 | $24.00 | $430,872.00 | (100%) 17.95K to 0 | < 1% |
| 29-Apr-13 2:48 PM View: | Fitzgibbons Albert J III Director | Obagi Medical Products, Inc. (OMPI) | 25-Apr-13 | Disposition | 17,953 | $24.00 | $430,872.00 | (100%) 17.95K to 0 | < 1% |
| 29-Apr-13 2:40 PM View: | Badie Ronald P Director | Obagi Medical Products, Inc. (OMPI) | 25-Apr-13 | Disposition | 18,952 | $24.00 | $454,848.00 | (100%) 18.95K to 0 | < 1% |
| 29-Apr-13 2:42 PM View: | Duerden John H Director | Obagi Medical Products, Inc. (OMPI) | 25-Apr-13 | Disposition | 15,426 | $24.00 | $370,224.00 | (100%) 15.43K to 0 | < 1% |
| 12-Sep-12 5:28 PM View: | Romm Preston S CFO and EVP | Obagi Medical Products, Inc. (OMPI) | 11-Sep-12 | Option Exercise | 77,827 | $10.00 | $778,270.00 | 100% 0 to 77.83K | |
| 12-Sep-12 5:28 PM View: | Romm Preston S CFO and EVP | Obagi Medical Products, Inc. (OMPI) | 11-Sep-12 | Market Option Sale | 77,827 | $13.21 | $1,027,910.00 | (100%) 77.83K to 0 | (81%) |
| 12-Sep-12 5:28 PM View: | Romm Preston S CFO and EVP | Obagi Medical Products, Inc. (OMPI) | 10-Sep-12 | Market Option Sale | 17,644 | $13.27 | $234,083.00 | (100%) 17.64K to 0 | (81%) |
| 12-Sep-12 5:28 PM View: | Romm Preston S CFO and EVP | Obagi Medical Products, Inc. (OMPI) | 10-Sep-12 | Option Exercise | 17,644 | $6.09 | $107,443.00 | 100% 0 to 17.64K | |
| 02-Aug-12 3:13 PM View: | Leslie Kristina M Director | Obagi Medical Products, Inc. (OMPI) | 31-Jul-12 | Grant | 4,890 | -- | -- | 100% 0 to 4.89K | |
| 08-Jun-12 12:45 PM View: | Fitzgibbons Albert J III Director | Obagi Medical Products, Inc. (OMPI) | 06-Jun-12 | Grant | 2,206 | -- | -- | 14% 15.75K to 17.95K | |
| 08-Jun-12 12:43 PM View: | Badie Ronald P Director | Obagi Medical Products, Inc. (OMPI) | 06-Jun-12 | Grant | 2,206 | -- | -- | 13% 16.75K to 18.95K | |
| 08-Jun-12 12:51 PM View: | Duerden John H Director | Obagi Medical Products, Inc. (OMPI) | 06-Jun-12 | Grant | 2,206 | -- | -- | 17% 13.22K to 15.43K | |
| 08-Jun-12 12:47 PM View: | Grant Edward A Director | Obagi Medical Products, Inc. (OMPI) | 06-Jun-12 | Grant | 2,206 | -- | -- | 12% 19.0K to 21.2K | |
| 08-Jun-12 12:42 PM View: | Bartholdson John A. Director | Obagi Medical Products, Inc. (OMPI) | 06-Jun-12 | Grant | 2,206 | -- | -- | 14% 15.75K to 17.95K | |
| 15-Mar-12 12:22 PM View: | Goldstein David S. Executive Vice President | Obagi Medical Products, Inc. (OMPI) | 13-Mar-12 | Option Exercise | 16,666 | $5.86 | $97,662.80 | 100% 0 to 16.67K | |
| 15-Mar-12 12:22 PM View: | Goldstein David S. Executive Vice President | Obagi Medical Products, Inc. (OMPI) | 13-Mar-12 | Market Option Sale | 16,666 | $12.51 | $208,483.00 | (100%) 16.67K to 0 | (92%) |
| 12-Dec-11 2:42 PM View: | Goldstein David S. Executive Vice President | Obagi Medical Products, Inc. (OMPI) | 09-Dec-11 | Market Option Sale | 32,334 | $9.75 | $315,256.00 | (59%) 54.83K to 22.5K | (146%) |
| 12-Dec-11 2:42 PM View: | Goldstein David S. Executive Vice President | Obagi Medical Products, Inc. (OMPI) | 09-Dec-11 | Option Exercise | 33,334 | $5.86 | $195,337.00 | 155% 21.5K to 54.83K | |
| 12-Dec-11 2:42 PM View: | Goldstein David S. Executive Vice President | Obagi Medical Products, Inc. (OMPI) | 09-Dec-11 | Market Sale | 22,500 | $9.75 | $219,375.00 | (100%) 22.5K to 0 | (146%) |
| 12-Dec-11 2:42 PM View: | Goldstein David S. Executive Vice President | Obagi Medical Products, Inc. (OMPI) | 08-Dec-11 | Market Option Sale | 1,000 | $9.84 | $9,841.00 | (4%) 22.5K to 21.5K | (144%) |
| 18-Nov-11 4:44 PM View: | Romm Preston S CFO and EVP | Obagi Medical Products, Inc. (OMPI) | 18-Nov-11 | Option Exercise | 13,179 | $5.86 | $77,228.90 | 100% 0 to 13.18K | |
| 18-Nov-11 4:44 PM View: | Romm Preston S CFO and EVP | Obagi Medical Products, Inc. (OMPI) | 18-Nov-11 | Market Option Sale | 13,179 | $9.72 | $128,056.00 | (100%) 13.18K to 0 | (147%) |
| 18-Nov-11 4:44 PM View: | Romm Preston S CFO and EVP | Obagi Medical Products, Inc. (OMPI) | 17-Nov-11 | Option Exercise | 10,569 | $5.86 | $61,934.30 | 100% 0 to 10.57K | |
| 18-Nov-11 4:44 PM View: | Romm Preston S CFO and EVP | Obagi Medical Products, Inc. (OMPI) | 17-Nov-11 | Market Option Sale | 10,569 | $9.83 | $103,841.00 | (100%) 10.57K to 0 | (144%) |
| 18-Nov-11 4:44 PM View: | Romm Preston S CFO and EVP | Obagi Medical Products, Inc. (OMPI) | 16-Nov-11 | Option Exercise | 9,586 | $5.86 | $56,174.00 | 100% 0 to 9.59K | |
| 18-Nov-11 4:44 PM View: | Romm Preston S CFO and EVP | Obagi Medical Products, Inc. (OMPI) | 16-Nov-11 | Market Option Sale | 9,586 | $9.96 | $95,504.80 | (100%) 9.59K to 0 | (141%) |
| 09-Jun-11 2:49 PM View: | Badie Ronald P Director | Obagi Medical Products, Inc. (OMPI) | 07-Jun-11 | Grant | 3,209 | -- | -- | 24% 13.54K to 16.75K | |
| 09-Jun-11 2:55 PM View: | Duerden John H Director | Obagi Medical Products, Inc. (OMPI) | 07-Jun-11 | Grant | 3,209 | -- | -- | 32% 10.01K to 13.22K | |
| 09-Jun-11 2:54 PM View: | Grant Edward A Director | Obagi Medical Products, Inc. (OMPI) | 07-Jun-11 | Grant | 3,209 | -- | -- | 20% 15.79K to 19.0K | |
| 09-Jun-11 2:51 PM View: | Bartholdson John A. Director | Obagi Medical Products, Inc. (OMPI) | 07-Jun-11 | Grant | 3,209 | -- | -- | 26% 12.54K to 15.75K | |
| 09-Jun-11 2:52 PM View: | Fitzgibbons Albert J III Director | Obagi Medical Products, Inc. (OMPI) | 07-Jun-11 | Grant | 3,209 | -- | -- | 26% 12.54K to 15.75K | |
| 25-Apr-11 1:58 PM View: | Hummel Albert F President & CEO Director | Obagi Medical Products, Inc. (OMPI) | 21-Apr-11 | Grant | 50,000 | -- | -- | 317% 15.79K to 65.79K | |
| 01-Dec-10 4:38 PM View: | Bartholdson John A. Director | Obagi Medical Products, Inc. (OMPI) | 30-Nov-10 | Disposition | 2,688,670 | $9.84 | $26,456,500.00 | (100%) 2.7M to 12.54K | (143%) |
| 01-Dec-10 4:38 PM View: | Fitzgibbons Albert J III Director | Obagi Medical Products, Inc. (OMPI) | 30-Nov-10 | Disposition | 2,688,670 | $9.84 | $26,456,500.00 | (100%) 2.7M to 12.54K | (143%) |
| 02-Dec-10 3:04 PM View: | Stonington Capital Apprecia... 10% Owner | Obagi Medical Products, Inc. (OMPI) | 30-Nov-10 | Market Sale | 2,688,670 | $9.84 | $26,456,500.00 | (100%) 2.69M to 0 | (143%) |
| 10-Jun-10 12:24 PM View: | Grant Edward A Director | Obagi Medical Products, Inc. (OMPI) | 08-Jun-10 | Grant | 2,463 | -- | -- | 18% 13.32K to 15.79K | |
| 10-Jun-10 12:22 PM View: | Bartholdson John A. Director | Obagi Medical Products, Inc. (OMPI) | 08-Jun-10 | Grant | 2,463 | -- | -- | < 1% 4.73M to 4.73M | |
| 10-Jun-10 12:33 PM View: | Fitzgibbons Albert J III Director | Obagi Medical Products, Inc. (OMPI) | 08-Jun-10 | Grant | 2,463 | -- | -- | < 1% 4.73M to 4.73M | |
| 10-Jun-10 12:25 PM View: | Hummel Albert F Director | Obagi Medical Products, Inc. (OMPI) | 08-Jun-10 | Grant | 2,463 | -- | -- | 18% 13.32K to 15.79K | |
| 10-Jun-10 12:20 PM View: | Badie Ronald P Director | Obagi Medical Products, Inc. (OMPI) | 08-Jun-10 | Grant | 2,463 | -- | -- | 22% 11.07K to 13.54K | |
| 10-Jun-10 12:31 PM View: | Duerden John H Director | Obagi Medical Products, Inc. (OMPI) | 08-Jun-10 | Grant | 2,463 | -- | -- | 33% 7.55K to 10.01K | |
| 14-May-10 1:10 PM View: | Goldstein David S. Executive Vice President | Obagi Medical Products, Inc. (OMPI) | 13-May-10 | Option Exercise | 8,601 | $10.76 | $92,557.20 | 38% 22.5K to 31.1K | |
| 14-May-10 1:10 PM View: | Goldstein David S. Executive Vice President | Obagi Medical Products, Inc. (OMPI) | 13-May-10 | Market Option Sale | 8,601 | $13.55 | $116,570.00 | (28%) 31.1K to 22.5K | (77%) |
| 14-May-10 1:10 PM View: | Goldstein David S. Executive Vice President | Obagi Medical Products, Inc. (OMPI) | 12-May-10 | Option Exercise | 41,817 | $8.41 | $351,623.00 | 186% 22.5K to 64.32K | |
| 14-May-10 1:10 PM View: | Goldstein David S. Executive Vice President | Obagi Medical Products, Inc. (OMPI) | 12-May-10 | Market Option Sale | 41,817 | $13.63 | $569,928.00 | (65%) 64.32K to 22.5K | (76%) |
| 22-Jun-09 1:59 PM View: | Fitzgibbons Albert J III Director | Obagi Medical Products, Inc. (OMPI) | 18-Jun-09 | Grant | 4,055 | -- | -- | < 1% 4.73M to 4.73M |
